1,819 reports of this reaction
1.8% of all VANCOMYCIN reports
#11 most reported adverse reaction
RASH is the #11 most commonly reported adverse reaction for VANCOMYCIN, manufactured by Hikma Pharmaceuticals USA Inc.. There are 1,819 FDA adverse event reports linking VANCOMYCIN to RASH. This represents approximately 1.8% of all 102,861 adverse event reports for this drug.
VANCOMYCIN has an overall safety score of 88 out of 100. Patients taking VANCOMYCIN who experience rash should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
RASH is a less commonly reported adverse event for VANCOMYCIN, but still significant enough to appear in the safety profile.
In addition to rash, the following adverse reactions have been reported for VANCOMYCIN:
The following drugs have also been linked to rash in FDA adverse event reports:
RASH has been reported as an adverse event in 1,819 FDA reports for VANCOMYCIN. This does not prove causation, but indicates an association observed in post-market surveillance data.
RASH accounts for approximately 1.8% of all adverse event reports for VANCOMYCIN, making it a notable side effect.
If you experience rash while taking VANCOMYCIN, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.